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Summary The comparative efficacy of the pure diastereoisomers of leucovorin, the natural (6S) and the
unnatural (6R) forms was compared to the racemic form (6RS). A protective effect in methotrexate-treated
CCRF-CEM cells was obtained with 6S at concentrations 100-fold higher than those of methotrexate and with
6RS at concentrations 2-fold greater than those of 6S; however, at low concentrations ofmethotrexate, 6S was
more effective than 6RS in preventing the cytotoxicity of methotrexate; on the opposite, 6R exhibited a
protective effect at concentrations 104 higher than those of methotrexate. On the same cell line, 6S was shown
to enhance the cytotoxic effect of 5 Fluorouracil exactly as 6RS while 6R did not exhibit any enhancing effect
on cells exposed to 5 Fluorouracil.
Leucovorin (folinic acid, 5 formyltetrahydrofolate) is a
reduced derivative of folic acid, with a formyl unit attached
to N5 position of tetrahydrofolate (THF). Among the
reduced folate derivatives, which are the biologically active
forms, leucovorin (LV) is the one that is chemically stable;
therefore it is used therapeutically, but the commercially
available LV is the racemic form, (6RS) consisting of equal
amounts of the diastereoisomers, 6S (I isomer) and 6R (d
isomer). It is generally accepted that only the natural isomer,
6S, is active while the unnatural isomer, 6R, is inactive
(Blackley, 1969; Straw et al., 1987). These two forms exhibit
major pharmacokinetic differences as shown on the short
half-time of I isomer, with a mean elimination half-time of
20-30 min as compared with a much slower clearance of the
d isomer (half-time of 6-11 h) (Machover et al., 1986; Straw
et al., 1987). These differences in pharmacokinetics of 6S and
6R isomers lead to an accumulation in the plasma of large
quantities of the 6R form which can interfere with the
biological activity of the 6S isomer form (Schilsky & Ratain,
1990). As it has been possible to obtain every isomer in a
high degree of purity, in vitro studies have been performed to
compare both isomers with 6RS and with themselves. This
comparison seemed to us interesting, because LV is more and
more clinically used not only to prevent toxicity after
intermediate and high doses methotrexate (MTX) therapy,
but also to enhance the cytotoxicity of 5 Fluorouracil (5 FU).
Indeed administration of LV increases the endogenous pools
of methylene-THF and thus induces a stabilisation of the
ternary complex formed by this folate cofactor, thymidylate
synthase (TS) and 5-fluorodeoxyuridylate (5 FdUMP). (Ull-
man et al., 1978; Evans et al., 1981; Yin et al., 1983;
Keyomarsi & Moran, 1986).
The comparative effect of 6S, 6R and 6RS-LV on MTX
rescue and on modulation of 5 FU cytotoxicity has been
studied on CCRF- CEM, a leukaemic lymphoblastic con-
tinuous cell line.
Materials and methods
Chemicals
Leucovorin, 6RS (d,l), 6S (1) and 6R (d) were kindly supplied
by Lederle Cyanamid, New Jersey. The degree of purity was
respectively 98.5% for 6S and 99.3% for 6R. Deoxyuridine
(dU), methotrexate (MTX) and Fluorouracil (5 FU) were
purchased from Sigma. 3H-6 thymidine (3H-TdR: 24 Ci
mmol 1) was purchased from the Radiochemical Centre,
Amersham.
Dry culture medium (RPMI 1640), and foetal calf serum
(FCS) were purchased from Boehringer. The medium was
reconstituted, treated with antibiotics (penicillin 100,000ul-1
streptomycin 100 mg I'), ultrafiltered and kept at + 4°C.
Cell culture
CCRF-CEM, a human lymphoblastic leukaemic cell line,
CALLA +, TdT +, was grown in RPMI medium, supple-
mented just before use with 10% heat-deactivated FCS
(45 min at 56C); cultures were initiated with 50 ml of cell
suspensions containing 1.105 cells ml- 1; medium was changed
twice a week. All the experiments were performed in log
growth phase of culture.
Deoxyuridine suppression test (dU ST)
The principle of this test consists in measuring the synthesis
of thymine-DNA through thymidylate (dTMP) biosynthesis
which proceeds via either the de novo or salvage pathway. In
the de novo pathway, this synthesis occurs through the con-
version of deoxyuridylate (dUMP) to dTMP which requires
TS and 5, 10 methylene THF. In the salvage pathway, pre-
formed thymidine (TdR) is phosphorylated to dTMP for
DNA synthesis. In normal cells, incorporation of preformed
3HTdR into DNA is almost completely suppressed by a
preincubation with cold dU (Killman, 1964; Metz et al.,
1968). The % of 3H-TdR falls from 100% to less than 15%
in continuous cell lines (Marquet et al., 1981) and even to
less than 10% in normal bone marrow cells (Zittoun et al.,
1978). On the contrary, in folate deficient cells or in cells
treated with MTX or 5 FU, this test becomes abnormal with
an increased % of 3HTdR into DNA after incubation with
cold dU (Metz, 1984). As the dU test measures DNA syn-
thesis on short times of cultures, this test was performed on
cells in log growth phase of culture.
This test was performed as previously described (Marquet
et al., 1981). 1.106cells ml-' were preincubated in the culture
medium + 10% FCS with exogenous cold dU (10-4 M) for
1 h; then, 1 ,.ci of 3H-TdR was added to all cultures and
incubation continued for 30 min. In some tubes, the same
amount of cells were incubated without dU for 1 h and then
added with 1 yci of 3H-TdR in order to obtain the 100% of
3H-TdR incorporated into DNA. Following incubation with
3H-TdR, the cells were washed three times in buffered saline
and resuspended in a final volume of 200pl. The cell suspen-
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sion was spotted on filter-paper discs and allowed to dry. The
discs were placed in 10% trichloracetic acid for 20 min then
washed twice in methanol and finally acetone. Radioactivity
was assayed by placing the discs directly into scintillant. The
drugs, MTX or 5 FU, added in cells were incubated along
with exogenous dU and then with 3H-TdR. MTX was tested
at concentrations ranging from 10-7 M to 10-5 M, which are
close to the drug levels achieved in plasma after administra-
tion of conventional or high doses of this drug. MTX was
added in the culture medium either alone or with LV at
concentrations ranging from 10-6M to 5.10-3M.
Preliminary experiments showed that 10-4 M 5 FU was the
optimal concentration. 10-7 M to 10-4 M 5 FU were tested on
the cell growth curve as well as on clonogenic cells. After 4
days of culture, growth curves in the presence of 10-' M and
10-6 M 5FU were close to those obtained in controls. With
I0- M 5 FU, the number of total cell division (TCD) corre-
sponding to log (N'/N'0)/log 2 was lower than that of con-
trols (2 v 3 TCD), while only 1 TCD was obtained after
addition of 10-4 M 5 FU. On clonogenic cells, 10-4 M FU
induced 57% of inhibition. In dUST, 5 FU was added alone
in the culture medium or after a pre-exposure of cells for 1 h
to LV at concentrations ranging from 10-6 M to 10-4 M.
In all experiments, the quantity of 6RS tested was 2-fold
greater than that tested with each of the isomers.
Colonyforming cells
CCRF-CEM cells were exposed respectively for 4 h to
10-4 M 5FU alone and for 2 h to 6S and to 6R at concentra-
tions ranging from 10-6 to 10-4 M and to 6RS at concentra-
tions 2-fold higher followed by an additional exposure of 4 h
to 10-4 M 5 FU along with LV as previously reported by
Mini et al. (1987). A control without drug was run simul-
taneously. After drug exposure, the cells were washed twice
with RPMI 1640 medium and resuspended in RPMI medium
containing 20% FCS and 10% of PHA-LCM prepared as
previously described (Buick et al., 1979) at a concentration of
106cellsml-'. The cells were then mixed with the same
volume of a solution of 1.4% methyl cellulose in RPMI
medium (v/v), then plated. The number of colonies was
determined after 4 days.
Statistical analysis
Comparison between means were performed by a two-way
ANOVA (drug effect - concentration effect) when the
number of data was equivalent. In this case, the level of
significance was set at a = 0.05 and the residual variance of
ANOVA used for comparison between two means. In case of
unequal number of data, Student's t-tests were performed. In
order to avoid an increase in first type error, the level of
significance was set at a = 0.01 (multiple comparisons) and
the pooled variance of the sample used for comparison
between two means.
Results
Effect ofLV (6S, 6R and6RS) on MTX treated cells
MTX added in vitro, even at low concentrations had a
marked effect on the dUST making it abnormal compared to
the control without drug (P < 10-2) (Table I). At low doses
of MTX (10-` M), simultaneous addition of 10-5 M 6S isomer
quite normalised the dUST while 6RS at 2-fold greater con-
centrations had only a partial corrective effect with a
significant difference between the two derivatives (P < 10-2).
From 4.10-5 M 6RS, the dUST equally reverted to normal as
with 2.10-5M 6S isomer. In the same range of concentra-
tions, 6R had no protective effect compared to the two other
forms (P < 10-4); however, addition of 6R isomer at concen-
trations 100-fold higher (10-' M) exerted a complete protec-
tive effect. When MTX was added at higher concentrations
(10-6 M), the rescue effect was obtained with 6S and 6RS at a
concentration respectively 100-fold and 200-fold higher with-
out any significant difference between the two forms used
(P = 0.69). The same results were observed when this rescue
effect was tested using 10-5 M of MTX. The dUST was
normalised after simultaneous addition of 6S 10-3 M isomer
or 2.10-3 M 6RS. No corrective effect was obtained even with
5.10-3 M of 6R isomer; higher concentrations of this isomer
could not be tested because ofthe solubility ofthe compound
which was a limiting factor.
Effect ofLV (6S, 6R and 6RS) on the cytotoxicity ofS FU
Figure 1 shows the variations of the dU suppression values
after preaddition of LV (6S, 6R and 6RS) followed by addi-
tion of 10-4 M 5 FU and dU. Addition of 10-4 M 5 FU along
with dU made the dUST abnormal compared to the control
without drug (P < 10-2). The pre-exposure of cells to 6S and
6RS LV at concentration ranging from 10-6 to 10-4 M made
the test significantly more abnormal than with 5 FU alone
with a degree of significance higher with 6S (P = 5.10-4)
than with 6RS (P = 0.01); however no significant difference
appeared between these two forms, whatever the concentra-
Table I dU suppression values after addition of MTX alone or with LV (normal: < 15%)
10-' m MTX
No. LV addition
LV addition
10-6 M
2.10-6 M
i0-5 M
2.10-5 M
2.10-5 M
4.10-5 M
10-4 M
2.10-4 M
10-3 M
2.10-3 M
5.10-3 M
36.7 ± 1.8a (35-38.6)b
6S 37.5±2
6R 37.2 ± 3.7
6RS 36± 2.3
6S 12.4 ± 0.9
6R 39 ±1
6RS 20.1 ± 0.9
6S
6R
6RS
(33.4-42)
(33-40)
(34-38.3)
(11-13.2)
(37.5-40)
(18.8-20.9)
10± 1.5 (8-11.5)
9.4 ± 1 (8.2-11.2)
6S 10± 1.8
6R 38.4 ± 1.4
6RS 10 ± 1.5
6S
6R
6RS
6R
(7.7-12.1)
(36-39.7)
(8-11.8)
10-6M MTX
37 ± 4.1 (32.5-40.5)
32.9 ± 2.1 (30.7-36)
36 3 (32-39)
39.7 ± 1.7 (37.2-41.3)
33.5 ± 0.5 (32.5-34)
37.8 4.8 (31.8-43)
36.4 ± 0.4 (35.8-36.8)
35 ± 5 (28.5-41)
13.6± 1 (12-14.8)
35.2 ± 2.8 (31.3-37.3)
15 1.5(13.2-17)
9± 1.2 (7.2-10) 39.5 ±4.5(35-44)
aMean ± s.d. and brange of three separate experiments.
10- AM MTX
36 ± 3.3 (32.5-39)
32.5 ± 1.7 (30.4-35)
36.5 ± 3.2 (32-39.9)
37 ± 1.5 (35-39.2)
15 ± 2 (11.5-18.5)
36.2 ± 1.4 (33.8-38.3)
15 ± 3 (10.7-15.8)
36.4 (35.7 37)
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Figure 1 dU suppression values expressed in % of 3HTdR into
DNA after cell exposure to 10 NM 5 FU vs 10-4 M 5 FU
leucovorin (LV) at different concentrations. Vertical bars indicate
standard error deviation of the mean of three separate
experiments. M, 6S-LV; 1, 6RS-LV; =1, 6R-LV.
tions tested (P = 0.94). Conversely, 6R isomer did not pro-
duce any additional cytotoxic effect since the dU suppression
values obtained with 5 FU alone or with 6R isomer were
very close (P = 0.83). The comparison between 6R and 6S or
6RS showed statistical differences (respectively P = 10-' and
2.10-4). In addition, these results were confirmed by the
reduced number of CFC obtained after cell exposure to 6S
and 6RS LV followed by 5 FU.
Figure 2 shows that exposure of CCRF-CEM cells to
10- M 5 FU alone exhibited a net cytotoxic effect on CFC,
since the number of CFC was less than half of the controls
(P < 10-4). A pre-exposure of cells to 6S or 6RS exhibited a
synergistic effect observed with concentrations ranging from
10-6 to 10' M. This difference was statistically significant
(P < 10-4), whatever the concentration tested, but no
difference appeared between the two derivatives (P = 0.16).
This synergistic effect became maximum at 10- M 6S or 6RS
and then reached a plateau at 10-4 M. On the contrary, 6R
isomer, whatever the concentrations tested, did not exhibit
any difference compared with 5 FU alone (P >0.2).
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Figure 2 Number of colony forming cells (CFC) after exposure
to I0-4M 5 FU alone or with LV at different concentrations.
Vertical bars indicate standard error deviation of the mean of six
separate experiments. 1, 6S-LV; M, 6RS-LV; M, 6R-LV.
Discussion
Active derivatives offolic acid are reduced forms, tetrahydro-
folate and its congeners. However, because of their in-
stability, they cannot be used therapeutically and are
replaced by leucovorin, directly converted to 5, 10 methenyl
THF by an ATP dependent enzyme, 5, 10 methenyl THF
synthetase. 5, 10 methenyl, 5, 10 methylene and 10 formyl
THF are interconvertible (Huennekens et al., 1987).
Given the large use of leucovorin, the present work shows
the effect of both isomers ofLV, 6S (I form) and 6R (d form)
compared to the racemic form, 6RS in different situations
where LV is active. The data confirm that only 6S isomer is
the active form and is at least as efficient as the racemic
form, whatever the conditions in which it has been evaluated;
whereas, the unnatural isomer, 6R is inactive except at very
high concentrations for rescue of low doses of MTX.
The three forms of LV have been evaluated on endogenous
thymidylate biosynthesis which is directly blocked by 5 FU
through inhibition of TS or indirectly by MTX through that
of dihydrofolate reductase (DHFR). At low concentrations
of MTX (10-7M) added in the culture medium, 6S isomer is
more efficient than the racemic form in reverting the block of
thymidylate syntlxesis through that of DHFR. At higher
concentrations of MTX, 6S and 6RS reverted the dUST to
normal in the same range of concentrations; whereas 6R
isomer exhibited a protective effect at concentrations 100-fold
higher and only for low concentrations of MTX. These
results are in agreement with the findings of Sirotnak et al.
(1979) on L1210 and Erlich cells. These authors observed
that the racemic form was 2-fold less effective than the I form
in preventing inhibition by MTX of L1210 cell growth in
culture while the unnatural diastereoisomer was 100-fold less
effective.
As leucovorin is now currently administered clinically in
combination with 5 FU in order to enhance that drug's
antitumor activity (Rustum et al., 1987), the efficacy of the
diastereoisomers has been tested to look for an enhancement
of 5 FU cytotoxicity. On CCRF-CEM cells, the cytotoxic
effect of 10- M 5 FU has been found enhanced by the
natural isomer, 6S and the racemic form in the same propor-
tions; indeed a reduction in the number of CFC was
observed compared to that obtained with 5 FU alone. In a
previous study, Mini et al. (1987) observed the same syner-
gistic inhibitory effect on cell growth of CCRF-CEM using
6RS and the same sequence of drug exposure. On the con-
trary, 6R isomer even at concentrations 100-fold higher did
not display any difference with the cytotoxicity obtained by
5 FU alone. The same results have been also observed, using
dUST made abnormal by the addition of 5 FU together with
dU. The addition of 6S or 6RS in the culture medium before
addition of 5 FU and dU worsened identically the abnor-
mality of the dUST, but no dose effect has been observed
with each of these compounds. It could be assumed that
there is a saturation in the cellular uptake of LV or in the
specific binding to proteins. Indeed Matherly et al. (1990)
have recently found that the protein bound fraction which is
saturable mainly comprised THF and methylene THF; in
fact this last cofactor has been shown to be essential for the
LV mediated enhancement of fluoropyrimidines. The
unnatural isomer, 6R did not exhibit any enhancement on
the cytotoxic effect of 5 FU, but did not seem to modify the
modulating effect of 6RS. Hakala et al. (1989) have also
observed that the intracellular stability of TS-FdUMP was
identical whether Hep cells were incubated with 6S or 6RS.
In addition, Lee & Shilsky (1990) have recently shown that
6S and 6R isomers exert, in a cell free system, a competitive
inhibition of TS with respect to methylene THF; however,
the concentration of 6S isomer required for 50% inhibition
was approximately 20 times less than that of the 6R isomer.
In conclusion, it appears that each of the diastereoisomers
of LV shows major differences in terms of efficacy and also
in pharmacokinetics as was shown previously (Machover et
al., 1986; Straw, 1987). Globally, the natural isomer is 2-fold
more effective than the racemic form as expected, and even888 J. ZITTOUN et al.
more efficient in reversing cytotoxicity of MTX at low doses.
The unnatural isomer 6R exerts an effect on the rescue of
MTX only at high concentrations. This slight action of 6R
could be due to the fact that this unnatural isomer probably
shares the same folate transport protein: on CCRF-CEM
cells, the 6R could competitively inhibit the uptake of the
natural isomer in defined anion-free buffers, but poorly in
complex culture medium (Bertrand & Jolivet, 1988a). One
can assume that after cell uptake, the 6R isomer can be
polyglutamylated by the folylpolyglutamate synthetase since
there is no stereospecificity of this enzyme and both isomers
are active substrates for this mammalian enzyme (McGuire et
al., 1980). However, one can ask how the 6R isomer can then
exert this effect even minimally, since methenyltetrahydro-
folate synthesis is stereospecific for 6S (Bertrand & Jolivet,
1988b).
In any case, given the difference of pharmacokinetics
observed with each of the two isomers and the high persisting
concentrations in blood of the 6R after IV injection, one
cannot exclude clinical consequences.
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